Genmab

Danish healthcare company

GEN Nasdaq Copenhagen ISIN DK0010272202 LEI 529900MTJPDPE4MHJ122
Follow Genmab Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2026 USD · IFRS
EPS, diluted -
Revenue by fiscal year
$3.1B
$3.7B
FY24 FY25

Source: ESEF annual reports · latest filing